Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Allergy|June 3, 2026
Microcrystalline tyrosine as a novel depot-forming agent in venom immunotherapy: a pre-clinical evaluation in bee-venom allergic miceMarta Paolucci, Agathe Duda, Lara Šošić, et al.
Frontiers in Immunology|December 16, 2020
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT<sup>®</sup>)Matthew D Heath, Mona O Mohsen, Pieter-Jan de Kam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 30, 2018
Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR SignalingDeborah S Leuthard, Agathe Duda, Sandra N Freiberger, et al.
Vaccines|July 26, 2019
<i>Zika Virus</i>-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of <i>Dengue Virus</i> InfectionGustavo Cabral-Miranda, Stephanie M Lim, Mona O Mohsen, et al.
Vaccines|February 26, 2020
Correction: <i>Zika Virus</i>-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of <i>Dengue Virus</i> Infection. <i>Vaccines</i> 2019, <i>7</i>, 72Gustavo Cabral-Miranda, Stephanie M Lim, Mona O Mohsen, et al.
Vaccines|September 28, 2017
Microcrystalline Tyrosine (MCT<sup>®</sup>): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in MalariaGustavo Cabral-Miranda, Matthew D Heath, Ariane C Gomes, et al.
Allergy|October 10, 2023
Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergyPascal S Krenger, Romano Josi, Jan Sobczak, et al.
Toxins|September 26, 2021
Venom Immunotherapy: From Proteins to Product to Patient ProtectionMartin Feindor, Matthew D Heath, Simon J Hewings, et al.
Vaccines|May 5, 2017
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivaxGustavo Cabral-Miranda, Matthew D Heath, Mona O Mohsen, et al.
Allergy|July 21, 2021
Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergyAlexander Heldner, Francesca Alessandrini, Dennis Russkamp, et al.
Pageof 3